Vital Farms (NASDAQ:VITL) Price Target Raised to $30.00

Vital Farms (NASDAQ:VITL - Get Free Report) had its target price lifted by stock analysts at Stifel Nicolaus from $22.00 to $30.00 in a report released on Friday, Benzinga reports. The brokerage presently has a "buy" rating on the stock. Stifel Nicolaus' price target suggests a potential upside of 11.11% from the stock's previous close.

VITL has been the subject of a number of other reports. Lake Street Capital lifted their price objective on Vital Farms from $26.00 to $32.00 and gave the company a "buy" rating in a research note on Wednesday. TheStreet raised Vital Farms from a "c" rating to a "b-" rating in a report on Monday, March 18th. Finally, William Blair initiated coverage on Vital Farms in a report on Wednesday, April 10th. They set an "outperform" rating for the company. Two investment analysts have rated the stock with a hold rating and five have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $23.00.

Vital Farms Stock Up 2.1 %

Vital Farms stock traded up $0.56 during midday trading on Friday, reaching $27.00. The company's stock had a trading volume of 393,893 shares, compared to its average volume of 409,020. The stock's 50-day simple moving average is $21.96 and its 200-day simple moving average is $16.53. The company has a debt-to-equity ratio of 0.05, a current ratio of 3.00 and a quick ratio of 2.49. Vital Farms has a 52-week low of $10.00 and a 52-week high of $27.37. The stock has a market capitalization of $1.13 billion, a P/E ratio of 46.16 and a beta of 0.89.

Vital Farms (NASDAQ:VITL - Get Free Report) last posted its earnings results on Thursday, March 7th. The company reported $0.17 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.14 by $0.03. The company had revenue of $135.81 million during the quarter, compared to analysts' expectations of $131.10 million. Vital Farms had a return on equity of 14.22% and a net margin of 5.42%. During the same quarter last year, the firm earned $0.04 earnings per share. On average, sell-side analysts expect that Vital Farms will post 0.77 EPS for the current year.

Insider Transactions at Vital Farms

In other news, CEO Russell Diez-Canseco sold 27,528 shares of the stock in a transaction that occurred on Monday, February 12th. The stock was sold at an average price of $15.49, for a total transaction of $426,408.72. Following the completion of the transaction, the chief executive officer now directly owns 223,568 shares of the company's stock, valued at approximately $3,463,068.32. The sale was disclosed in a document filed with the SEC, which is accessible through this link. In related news, Chairman Matthew Ohayer sold 100,000 shares of the firm's stock in a transaction that occurred on Thursday, March 14th. The stock was sold at an average price of $21.38, for a total value of $2,138,000.00. Following the completion of the transaction, the chairman now directly owns 7,582,777 shares of the company's stock, valued at approximately $162,119,772.26. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Russell Diez-Canseco sold 27,528 shares of the firm's stock in a transaction that occurred on Monday, February 12th. The shares were sold at an average price of $15.49, for a total value of $426,408.72. Following the completion of the transaction, the chief executive officer now directly owns 223,568 shares of the company's stock, valued at $3,463,068.32. The disclosure for this sale can be found here. In the last three months, insiders sold 260,125 shares of company stock valued at $5,580,996. Corporate insiders own 30.20% of the company's stock.

Hedge Funds Weigh In On Vital Farms

Several hedge funds have recently bought and sold shares of VITL. Zurcher Kantonalbank Zurich Cantonalbank increased its position in Vital Farms by 52.8% during the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 8,196 shares of the company's stock worth $95,000 after buying an additional 2,833 shares in the last quarter. Tower Research Capital LLC TRC increased its position in Vital Farms by 211.4% during the fourth quarter. Tower Research Capital LLC TRC now owns 6,175 shares of the company's stock worth $97,000 after buying an additional 4,192 shares in the last quarter. Connor Clark & Lunn Investment Management Ltd. purchased a new position in Vital Farms during the third quarter worth $119,000. DekaBank Deutsche Girozentrale acquired a new stake in shares of Vital Farms during the fourth quarter worth $127,000. Finally, New York State Common Retirement Fund boosted its holdings in shares of Vital Farms by 49.0% during the fourth quarter. New York State Common Retirement Fund now owns 10,169 shares of the company's stock worth $160,000 after purchasing an additional 3,346 shares during the last quarter. Hedge funds and other institutional investors own 98.59% of the company's stock.

About Vital Farms

Vital Farms, Inc, a food company, provides pasture-raised products in the United States. It offers shell eggs, butter, hard-boiled eggs, and liquid whole eggs. The company was founded in 2007 and is headquartered in Austin, Texas.